You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
A systematic review of the epidemiology of carbapenem-resistant Enterobacteriaceae in the United States
|
|---|---|
| Published in |
Antimicrobial Resistance & Infection Control, April 2018
|
| DOI | 10.1186/s13756-018-0346-9 |
| Pubmed ID | |
| Authors |
Daniel J. Livorsi, Margaret L. Chorazy, Marin L. Schweizer, Erin C. Balkenende, Amy E. Blevins, Rajeshwari Nair, Matthew H. Samore, Richard E. Nelson, Karim Khader, Eli N. Perencevich |
| Abstract |
Carbapenem-resistant Enterobacteriaceae (CRE) pose an urgent public health threat in the United States. An important step in planning and monitoring a national response to CRE is understanding its epidemiology and associated outcomes. We conducted a systematic literature review of studies that investigated incidence and outcomes of CRE infection in the US. We performed searches in MEDLINE via Ovid, CDSR, DARE, CENTRAL, NHS EED, Scopus, and Web of Science for articles published from 1/1/2000 to 2/1/2016 about the incidence and outcomes of CRE at US sites. Five studies evaluated incidence, but many used differing definitions for cases. Across the entire US population, the reported incidence of CRE was 0.3-2.93 infections per 100,000 person-years. Infection rates were highest in long-term acute-care (LTAC) hospitals. There was insufficient data to assess trends in infection rates over time. Four studies evaluated outcomes. Mortality was higher in CRE patients in some but not all studies. While the incidence of CRE infections in the United States remains low on a national level, the incidence is highest in LTACs. Studies assessing outcomes in CRE-infected patients are limited in number, small in size, and have reached conflicting results. Future research should measure a variety of clinical outcomes and adequately adjust for confounders to better assess the full burden of CRE. |
X Demographics
The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 5 | 42% |
| Canada | 1 | 8% |
| Ukraine | 1 | 8% |
| Unknown | 5 | 42% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 58% |
| Scientists | 3 | 25% |
| Science communicators (journalists, bloggers, editors) | 1 | 8% |
| Practitioners (doctors, other healthcare professionals) | 1 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 163 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 163 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 26 | 16% |
| Researcher | 22 | 13% |
| Student > Bachelor | 18 | 11% |
| Student > Ph. D. Student | 15 | 9% |
| Student > Doctoral Student | 8 | 5% |
| Other | 17 | 10% |
| Unknown | 57 | 35% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 32 | 20% |
| Immunology and Microbiology | 19 | 12% |
| Biochemistry, Genetics and Molecular Biology | 12 | 7% |
| Agricultural and Biological Sciences | 9 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 6% |
| Other | 19 | 12% |
| Unknown | 63 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 June 2018.
All research outputs
#4,812,506
of 24,003,070 outputs
Outputs from Antimicrobial Resistance & Infection Control
#546
of 1,347 outputs
Outputs of similar age
#89,392
of 329,894 outputs
Outputs of similar age from Antimicrobial Resistance & Infection Control
#18
of 34 outputs
Altmetric has tracked 24,003,070 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,347 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.6. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 329,894 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.